Clinical Trial Update: A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares HRS9531 injection with semaglutide in adults with obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS9531
• semaglutide (semaglutide)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING